Skip to main content
. 2016 Dec 25;8(6):9686–9695. doi: 10.18632/oncotarget.14195

Table 1. Baseline Characteristics of acute coronary syndrome and control subjects.

Clinical variables NCn=40 UAn=42 NSTEMIn=41 STEMIn=41
Age (yrs) 67.29±9.58 64.00±12.54 70.31±14.90 66.94±16.35
Gender (male) 26(65%) 29(69%) 25(61%) 30(73%)
Current smoker 0 21(50%) 16(39%) 20(49%)
SBP (mmHg) 129.24±22.24 152.30±28.92 154.22±26.21 135.0±031.42
DBP (mmHg) 77.96±13.20 82.93±14.44 84.72±16.24 72.31±18.66
HR (/minute) 82.62±24.75 81.30±15.27 87.53±20.09 82.62±24.75
LVEF 75.12±8.41 57.12±11.53 45.32±11.54* 35.42±7.35*
BMI (kg/m2) 19.21±2.14 20.14±2.63 21.78±3.54 22.41±3.87§
WBC (x109/l) 5.65±1.38 7.91±2.66 9.65±3.77 12.70±3.44*
Creatinine (μmol/l) 71.93±19.12 86.93±16.59 150.50±187.00 155.81±160.86
Fasting glucose (hightest) (mmol/l) 5.21±0.33 5.80±1.18 6.65±2.49 7.18±2.30
HbA1c (mmol/mol) 47.62±14.65 47.05±9.08 52.25±13.05 50.00±13.87
TG (mmol/l) 1.36±0.63 1.58±0.92 1.71±0.88 1.79±1.50
TC (mmol/l) 5.16±0.54 4.86±1.30 4.54±0.82 4.71±0.82
HDL-C (mmol/l) 1.20±0.39 1.15±0.28 1.10±0.33 1.02±0.34
LDL-C (mmol/l) 3.02±0.37 3.07±1.18 2.67±0.71 2.96±0.84
Peak cTnT (μg/l) NA 0.023±0.03 0.76±1.12 3.80±5.77*
Peak CPK (U/L) NA 255.80±371.35 641.46±834.57§ 2667.31±1974.44*
Treatment
 PCI NA 18(42%) 22(54%) 24(59%)
 CABG NA 0 0 4(10%)*
 Aspirin NA 39(93%) 39(95%) 40(98%)
 Clopidogrel NA 12(28%) 19(46%) 31(76%)
 LMWH NA 35(83%) 37(90%) 36(87%)
 Statin NA 27(64%) 32(78%) 39(95%)

* p<0.05 vs NA, UA, NSTEMI, # p<0.05 vs NSTEMI, §p<0.05 vs NA and UA

The data are given as the mean ± SE or number of patients. SBP=systolic blood pressure, DBP=diastolic blood pressure, HR=heart rate, BMI=body mass index, WBC=white blood cell, HbA1c=glycoseylated hemoglobin, TG=Triglyceride, TC=Serum total cholesterol, HDL-C=High density lipoprotein cholesterol, LDL-C=Low density lipoprotein cholesterol, Peak cTnT=Peak troponin T, Peak CPK=Peak creatine kinase; PCI= Percutaneous Coronary Intervention; CABG= coronary artery bypass graft; LMWH= low molecular weight heparin